The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NK
1.2.3 LAK
1.2.4 DC
1.2.5 CIK
1.2.6 CTL
1.2.7 TIL
1.2.8 TCR-T
1.2.9 CAR-T
1.3 Market by Application
1.3.1 Global Adoptive Cell Transfer Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Acute Lymphocytic Leukemia
1.3.3 NHL
1.3.4 Melanoma
1.3.5 Bladder Cancer
1.3.6 Lung Cancer
1.3.7 Head and Neck Cancer
1.3.8 Multiple Myeloma
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Transfer Therapy Market Perspective (2019-2030)
2.2 Adoptive Cell Transfer Therapy Growth Trends by Region
2.2.1 Global Adoptive Cell Transfer Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adoptive Cell Transfer Therapy Historic Market Size by Region (2019-2024)
2.2.3 Adoptive Cell Transfer Therapy Forecasted Market Size by Region (2025-2030)
2.3 Adoptive Cell Transfer Therapy Market Dynamics
2.3.1 Adoptive Cell Transfer Therapy Industry Trends
2.3.2 Adoptive Cell Transfer Therapy Market Drivers
2.3.3 Adoptive Cell Transfer Therapy Market Challenges
2.3.4 Adoptive Cell Transfer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue (2019-2024)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Transfer Therapy Revenue
3.4 Global Adoptive Cell Transfer Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Transfer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Transfer Therapy Revenue in 2023
3.5 Adoptive Cell Transfer Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Transfer Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Transfer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Transfer Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Type (2019-2024)
4.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2025-2030)
5 Adoptive Cell Transfer Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Application (2019-2024)
5.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adoptive Cell Transfer Therapy Market Size (2019-2030)
6.2 North America Adoptive Cell Transfer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Adoptive Cell Transfer Therapy Market Size by Country (2019-2024)
6.4 North America Adoptive Cell Transfer Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adoptive Cell Transfer Therapy Market Size (2019-2030)
7.2 Europe Adoptive Cell Transfer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Country (2019-2024)
7.4 Europe Adoptive Cell Transfer Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size (2019-2030)
8.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adoptive Cell Transfer Therapy Market Size (2019-2030)
9.2 Latin America Adoptive Cell Transfer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2019-2024)
9.4 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size (2019-2030)
10.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Introduction
11.1.4 Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Detail
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Introduction
11.2.4 Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.2.5 Kite Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Adoptive Cell Transfer Therapy Introduction
11.3.4 Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Detail
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.4.5 Juno Therapeutics Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Introduction
11.5.4 Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.5.5 Celgene Corporation Recent Development
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Detail
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.6.5 CARsgen Therapeutics Recent Development
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Detail
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.7.5 Sorrento Therapeutics Recent Development
11.8 Legend Biotech
11.8.1 Legend Biotech Company Detail
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Introduction
11.8.4 Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.8.5 Legend Biotech Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Detail
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Detail
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Introduction
11.10.4 Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.10.5 Aurora Biopharma Recent Development
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Detail
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.11.5 Autolus Therapeutics PLC Recent Development
11.12 Bluebird
11.12.1 Bluebird Company Detail
11.12.2 Bluebird Business Overview
11.12.3 Bluebird Adoptive Cell Transfer Therapy Introduction
11.12.4 Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.12.5 Bluebird Recent Development
11.13 Carina Biotech
11.13.1 Carina Biotech Company Detail
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Introduction
11.13.4 Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.13.5 Carina Biotech Recent Development
11.14 Athenex
11.14.1 Athenex Company Detail
11.14.2 Athenex Business Overview
11.14.3 Athenex Adoptive Cell Transfer Therapy Introduction
11.14.4 Athenex Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.14.5 Athenex Recent Development
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Detail
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Introduction
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Detail
11.16.2 Hengrui Yuanzheng Business Overview
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Introduction
11.16.4 Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.16.5 Hengrui Yuanzheng Recent Development
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Detail
11.17.2 Eureka Therapeutics Business Overview
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Introduction
11.17.4 Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.17.5 Eureka Therapeutics Recent Development
11.18 WuXi Juno
11.18.1 WuXi Juno Company Detail
11.18.2 WuXi Juno Business Overview
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Introduction
11.18.4 WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.18.5 WuXi Juno Recent Development
11.19 Shenzhen Inno Immunity
11.19.1 Shenzhen Inno Immunity Company Detail
11.19.2 Shenzhen Inno Immunity Business Overview
11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Introduction
11.19.4 Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.19.5 Shenzhen Inno Immunity Recent Development
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Detail
11.20.2 Shenzhen Binde Bio Business Overview
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Introduction
11.20.4 Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.20.5 Shenzhen Binde Bio Recent Development
11.21 Kerui Bio
11.21.1 Kerui Bio Company Detail
11.21.2 Kerui Bio Business Overview
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Introduction
11.21.4 Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.21.5 Kerui Bio Recent Development
11.22 Adaptimmune
11.22.1 Adaptimmune Company Detail
11.22.2 Adaptimmune Business Overview
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Introduction
11.22.4 Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.22.5 Adaptimmune Recent Development
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Detail
11.23.2 Altor Bioscience Corporation Business Overview
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Introduction
11.23.4 Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.23.5 Altor Bioscience Corporation Recent Development
11.24 Cellectis
11.24.1 Cellectis Company Detail
11.24.2 Cellectis Business Overview
11.24.3 Cellectis Adoptive Cell Transfer Therapy Introduction
11.24.4 Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.24.5 Cellectis Recent Development
11.25 Takara Bio
11.25.1 Takara Bio Company Detail
11.25.2 Takara Bio Business Overview
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Introduction
11.25.4 Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.25.5 Takara Bio Recent Development
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Detail
11.26.2 Unum Therapeutics Business Overview
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Introduction
11.26.4 Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024)
11.26.5 Unum Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of NK
Table 3. Key Players of LAK
Table 4. Key Players of DC
Table 5. Key Players of CIK
Table 6. Key Players of CTL
Table 7. Key Players of TIL
Table 8. Key Players of TCR-T
Table 9. Key Players of CAR-T
Table 10. Global Adoptive Cell Transfer Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Adoptive Cell Transfer Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Adoptive Cell Transfer Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Adoptive Cell Transfer Therapy Market Share by Region (2019-2024)
Table 14. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Adoptive Cell Transfer Therapy Market Share by Region (2025-2030)
Table 16. Adoptive Cell Transfer Therapy Market Trends
Table 17. Adoptive Cell Transfer Therapy Market Drivers
Table 18. Adoptive Cell Transfer Therapy Market Challenges
Table 19. Adoptive Cell Transfer Therapy Market Restraints
Table 20. Global Adoptive Cell Transfer Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 21. Global Adoptive Cell Transfer Therapy Market Share by Players (2019-2024)
Table 22. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Transfer Therapy as of 2023)
Table 23. Ranking of Global Top Adoptive Cell Transfer Therapy Companies by Revenue (US$ Million) in 2023
Table 24. Global 5 Largest Players Market Share by Adoptive Cell Transfer Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Adoptive Cell Transfer Therapy Product Solution and Service
Table 27. Date of Enter into Adoptive Cell Transfer Therapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Adoptive Cell Transfer Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2019-2024)
Table 31. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 32. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2025-2030)
Table 33. Global Adoptive Cell Transfer Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2019-2024)
Table 35. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2025-2030)
Table 37. North America Adoptive Cell Transfer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Adoptive Cell Transfer Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Adoptive Cell Transfer Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Adoptive Cell Transfer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Europe Adoptive Cell Transfer Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Europe Adoptive Cell Transfer Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Asia-Pacific Adoptive Cell Transfer Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 44. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 45. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 46. Latin America Adoptive Cell Transfer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 48. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 49. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 50. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 51. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 52. Novartis AG Company Detail
Table 53. Novartis AG Business Overview
Table 54. Novartis AG Adoptive Cell Transfer Therapy Product
Table 55. Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 56. Novartis AG Recent Development
Table 57. Kite Pharma Company Detail
Table 58. Kite Pharma Business Overview
Table 59. Kite Pharma Adoptive Cell Transfer Therapy Product
Table 60. Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 61. Kite Pharma Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Adoptive Cell Transfer Therapy Product
Table 65. Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Juno Therapeutics Company Detail
Table 68. Juno Therapeutics Business Overview
Table 69. Juno Therapeutics Adoptive Cell Transfer Therapy Product
Table 70. Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 71. Juno Therapeutics Recent Development
Table 72. Celgene Corporation Company Detail
Table 73. Celgene Corporation Business Overview
Table 74. Celgene Corporation Adoptive Cell Transfer Therapy Product
Table 75. Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 76. Celgene Corporation Recent Development
Table 77. CARsgen Therapeutics Company Detail
Table 78. CARsgen Therapeutics Business Overview
Table 79. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product
Table 80. CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 81. CARsgen Therapeutics Recent Development
Table 82. Sorrento Therapeutics Company Detail
Table 83. Sorrento Therapeutics Business Overview
Table 84. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product
Table 85. Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 86. Sorrento Therapeutics Recent Development
Table 87. Legend Biotech Company Detail
Table 88. Legend Biotech Business Overview
Table 89. Legend Biotech Adoptive Cell Transfer Therapy Product
Table 90. Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 91. Legend Biotech Recent Development
Table 92. Atara Biotherapeutics Company Detail
Table 93. Atara Biotherapeutics Business Overview
Table 94. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product
Table 95. Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 96. Atara Biotherapeutics Recent Development
Table 97. Aurora Biopharma Company Detail
Table 98. Aurora Biopharma Business Overview
Table 99. Aurora Biopharma Adoptive Cell Transfer Therapy Product
Table 100. Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 101. Aurora Biopharma Recent Development
Table 102. Autolus Therapeutics PLC Company Detail
Table 103. Autolus Therapeutics PLC Business Overview
Table 104. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product
Table 105. Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 106. Autolus Therapeutics PLC Recent Development
Table 107. Bluebird Company Detail
Table 108. Bluebird Business Overview
Table 109. Bluebird Adoptive Cell Transfer Therapy Product
Table 110. Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 111. Bluebird Recent Development
Table 112. Carina Biotech Company Detail
Table 113. Carina Biotech Business Overview
Table 114. Carina Biotech Adoptive Cell Transfer Therapy Product
Table 115. Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 116. Carina Biotech Recent Development
Table 117. Athenex Company Detail
Table 118. Athenex Business Overview
Table 119. Athenex Adoptive Cell Transfer Therapy Product
Table 120. Athenex Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 121. Athenex Recent Development
Table 122. Xiangxue Pharmaceutical (Xiangxue Precision) Company Detail
Table 123. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
Table 124. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product
Table 125. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 126. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
Table 127. Hengrui Yuanzheng Company Detail
Table 128. Hengrui Yuanzheng Business Overview
Table 129. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product
Table 130. Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 131. Hengrui Yuanzheng Recent Development
Table 132. Eureka Therapeutics Company Detail
Table 133. Eureka Therapeutics Business Overview
Table 134. Eureka Therapeutics Adoptive Cell Transfer Therapy Product
Table 135. Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 136. Eureka Therapeutics Recent Development
Table 137. WuXi Juno Company Detail
Table 138. WuXi Juno Business Overview
Table 139. WuXi Juno Adoptive Cell Transfer Therapy Product
Table 140. WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 141. WuXi Juno Recent Development
Table 142. Shenzhen Inno Immunity Company Detail
Table 143. Shenzhen Inno Immunity Business Overview
Table 144. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product
Table 145. Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 146. Shenzhen Inno Immunity Recent Development
Table 147. Shenzhen Binde Bio Company Detail
Table 148. Shenzhen Binde Bio Business Overview
Table 149. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product
Table 150. Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 151. Shenzhen Binde Bio Recent Development
Table 152. Kerui Bio Company Detail
Table 153. Kerui Bio Business Overview
Table 154. Kerui Bio Adoptive Cell Transfer Therapy Product
Table 155. Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 156. Kerui Bio Recent Development
Table 157. Adaptimmune Company Detail
Table 158. Adaptimmune Business Overview
Table 159. Adaptimmune Adoptive Cell Transfer Therapy Product
Table 160. Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 161. Adaptimmune Recent Development
Table 162. Altor Bioscience Corporation Company Detail
Table 163. Altor Bioscience Corporation Business Overview
Table 164. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product
Table 165. Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 166. Altor Bioscience Corporation Recent Development
Table 167. Cellectis Company Detail
Table 168. Cellectis Business Overview
Table 169. Cellectis Adoptive Cell Transfer Therapy Product
Table 170. Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 171. Cellectis Recent Development
Table 172. Takara Bio Company Detail
Table 173. Takara Bio Business Overview
Table 174. Takara Bio Adoptive Cell Transfer Therapy Product
Table 175. Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 176. Takara Bio Recent Development
Table 177. Unum Therapeutics Company Detail
Table 178. Unum Therapeutics Business Overview
Table 179. Unum Therapeutics Adoptive Cell Transfer Therapy Product
Table 180. Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2019-2024) & (US$ Million)
Table 181. Unum Therapeutics Recent Development
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Transfer Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Adoptive Cell Transfer Therapy Market Share by Type: 2023 VS 2030
Figure 3. NK Features
Figure 4. LAK Features
Figure 5. DC Features
Figure 6. CIK Features
Figure 7. CTL Features
Figure 8. TIL Features
Figure 9. TCR-T Features
Figure 10. CAR-T Features
Figure 11. Global Adoptive Cell Transfer Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Adoptive Cell Transfer Therapy Market Share by Application: 2023 VS 2030
Figure 13. Acute Lymphocytic Leukemia Case Studies
Figure 14. NHL Case Studies
Figure 15. Melanoma Case Studies
Figure 16. Bladder Cancer Case Studies
Figure 17. Lung Cancer Case Studies
Figure 18. Head and Neck Cancer Case Studies
Figure 19. Multiple Myeloma Case Studies
Figure 20. Other Case Studies
Figure 21. Adoptive Cell Transfer Therapy Report Years Considered
Figure 22. Global Adoptive Cell Transfer Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 23. Global Adoptive Cell Transfer Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 24. Global Adoptive Cell Transfer Therapy Market Share by Region: 2023 VS 2030
Figure 25. Global Adoptive Cell Transfer Therapy Market Share by Players in 2023
Figure 26. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Transfer Therapy as of 2023)
Figure 27. The Top 10 and 5 Players Market Share by Adoptive Cell Transfer Therapy Revenue in 2023
Figure 28. North America Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. North America Adoptive Cell Transfer Therapy Market Share by Country (2019-2030)
Figure 30. United States Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Canada Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Adoptive Cell Transfer Therapy Market Share by Country (2019-2030)
Figure 34. Germany Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. France Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. U.K. Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Italy Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Russia Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Nordic Countries Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Asia-Pacific Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Asia-Pacific Adoptive Cell Transfer Therapy Market Share by Region (2019-2030)
Figure 42. China Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Japan Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Latin America Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Latin America Adoptive Cell Transfer Therapy Market Share by Country (2019-2030)
Figure 50. Mexico Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Brazil Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Adoptive Cell Transfer Therapy Market Share by Country (2019-2030)
Figure 54. Turkey Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Adoptive Cell Transfer Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Novartis AG Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 57. Kite Pharma Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 59. Juno Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 60. Celgene Corporation Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 61. CARsgen Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 62. Sorrento Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 63. Legend Biotech Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 64. Atara Biotherapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 65. Aurora Biopharma Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 66. Autolus Therapeutics PLC Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 67. Bluebird Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 68. Carina Biotech Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 69. Athenex Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 70. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 71. Hengrui Yuanzheng Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 72. Eureka Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 73. WuXi Juno Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 74. Shenzhen Inno Immunity Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 75. Shenzhen Binde Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 76. Kerui Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 77. Adaptimmune Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 78. Altor Bioscience Corporation Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 79. Cellectis Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 80. Takara Bio Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 81. Unum Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2019-2024)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed